Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Zhangixalus omeimontis

ABSTRACT: Zhangixalus omeimontis Genome sequencing and assembly

PROVIDER: PRJNA1001901 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR25517597.fastq.gz	Fastqsanger.gz

Items per page:

1 - 1 of 1

Similar Datasets

Zhangixalus omeimontis

Project description:Zhangixalus omeimontis Transcriptome or Gene expression

| PRJNA529065 | ENA

Zhangixalus omeimontis

Project description:Rhacophorus omeimontis overview

| PRJNA630322 | ENA

Zhangixalus dugritei

Project description:Zhangixalus dugritei Genome sequencing and assembly,

| PRJNA949196 | ENA

Zhangixalus chenfui

Project description:Zhangixalus chenfui Genome sequencing and assembly

| PRJNA1010143 | ENA

Rana omeimontis

Project description:Rana omeimontis overview

| PRJNA407243 | ENA

Zhangixalus dugritei

Project description:Zhangixalus dugritei overview

| PRJNA950175 | ENA

Metabolic basis of metamorphic climax in the wood frog, Rana omeimontis

Project description:In this study, we compared the metabolic networks in the liver and tail between pro-metamorphic and climax metamorphic (natural and T3-driven) Rana omeimontis tadpoles by a combination of metabolomics and transcriptomics.

2020-10-01 | GSE147618 | GEO

Metabolic basis of metamorphic climax in the wood frog, Rana omeimontis

Project description:Metabolic basis of metamorphic climax in the wood frog, Rana omeimontis

| PRJNA615804 | ENA

Zhangixalus dugritei

Project description:The complete mitochondrial genome of Rhacophorus dugritei

| PRJNA764018 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data